A Phase II Efficacy Trial of Pazopanib in Non-Clear Cell Metastatic Renal Cell Cancer (mRCC) PINCR
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Pazopanib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 02 Feb 2018 Status changed from recruiting to active, no longer recruiting.
- 07 Sep 2017 Status changed from suspended to recruiting.
- 23 Aug 2017 Status changed from active, no longer recruiting to suspended.